Acute coronary syndrome: Relationship between genetic variants and TIMI risk
Viviane do Carmo Vasconcelos de Carvalho1, Lílian Caroliny Amorim Silva1, Romário Martins Araújo1
1Laboratório de Imunologia e Biologia Molecular, Departamento de Imunologia, Instituto Aggeu Magalhães, Fiocruz - PE, Av. Professor Moraes Rego, s/n, Cidade Universitária, Zipe Code: 50.740-465, Recife, PE, Brazil.
Insights
Genetic variants in IL6R and TNFa genes are associated with Acute Coronary Syndrome (ACS). The IL6R TT genotype may protect against ACS and reduce inflammatory markers, suggesting a link between genetics and cardiovascular disease risk.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
- Immunogenetics
Background:
- Acute Coronary Syndrome (ACS) is a complex disease influenced by genetic factors and coronary artery obstruction.
- Genetic variants in genes like IL6R, TNFa, LEPR, and IL1b have been implicated as potential risk factors for ACS.
- Early diagnosis and risk stratification using Thrombolysis in Myocardial Infarction (TIMI) risk are crucial for ACS management.
Purpose of the Study:
- To investigate the association of specific genetic variants in IL6R, TNFa, LEPR, and IL1b genes with ACS.
- To evaluate the relationship between these genetic variants, TIMI risk scores, serum cytokine levels, and common ACS risk factors.
- To explore the potential protective role of certain genotypes against ACS and their impact on inflammatory markers.
Main Methods:
- Genotyping of IL6R (c950-1722C>T), TNFa (c.-488G>A), LEPR (c.2673+1118C>T), and IL1b (c.-598T>C) variants using DNA sequencing or enzymatic cleavage.
- Selection of 200 ACS patients, 50 non-ACS patients, and 295 blood donors for comparative analysis.
- Measurement of serum cytokine levels (e.g., TNF-α) using ELISA and assessment of risk factors like dyslipidemia and hypertension.
Main Results:
- Hypertension was a frequent risk factor in ACS patients and correlated with high TIMI risk (p=0.003).
- Significant differences in genotype frequencies for IL6R (p=0.0002) and TNFa (p=0.01) were observed between ACS patients and blood donors.
- The IL6R TT genotype, more prevalent in blood donors and low TIMI risk individuals, was associated with lower c-reactive protein and troponin levels in ACS patients, indicating reduced inflammation and tissue damage.
Conclusions:
- Genetic variants in IL6R and TNFa play a role in the susceptibility to ACS.
- The IL6R TT genotype may confer a protective effect against ACS and is associated with a less severe inflammatory response.
- These findings underscore the importance of population-specific genetic studies in understanding the interplay between genetic factors and cardiovascular diseases like ACS.
Abstract:
Acute Coronary Syndrome (ACS) is a multifactorial disease, including the genetic factor, caused by coronary artery obstruction by atheroma. Some genetic variants have been described as risk factors for this disease. Its early diagnosis and stratification of risk of death by Thrombolysis in Myocardial Infarction (TIMI) are important. Therefore, we evaluated variants in the IL6R (c950-1722C>T), TNFa (c.-488G>A), LEPR (c.2673+1118C>T) and IL1b (c.-598T>C) genes in relation to TIMI risk, cytokine serum levels, and risk factors for ACS. We selected 200 patients with ACS, 50 without ACS from the Real Hospital Português, Recife - PE, and 295 blood donors at the Fundação de Hematologia e Hemoterapia de Pernambuco (Hemope). Variants were determined by DNA sequencing or enzymatic cleavage. Cytokine levels were measured by ELISA. The most frequent risk factors found in the patients were dyslipidemia and hypertension, this latter associated with high TIMI risk (p = 0.003). Genotype frequencies of IL6R and TNFa differed between patients with ACS and the blood donors (p = 0.0002 and p = 0.01, respectively), and TNF-α levels differed between genotypes. The TT genotype of the IL6R gene is as a possible protective factor for ACS because it was significantly more present in blood donors (32.2%) than in patients with ACS (18.0%), and was more frequent in low TIMI risk (22.9%) than in the intermediate (20.2%) or high (4.9%). In patients with ACS, the TT genotype in IL6R was related to a lower concentration of c-reactive protein (p = 0.03) and troponin (p = 0.02), showing a less inflammatory reaction and tissue damage. The differences in the frequencies of variants in genes of medical interest among the groups show the importance of studies in specific populations groups to establish the relationship between genes and diseases.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Relationship Formation


